Join Lachman Consultants (Ireland) in Leipzig, Germany for the 2023 Parenteral Drug Association (PDA) Good Aseptic Manufacturing Conference on May 23 – 24, to discuss the implications of the new GMP Annex 1 and share insights to help you prepare. As a Gold Sponsor at this year’s event, Lachman will be represented by:
- John Darby, Senior Director
- Martha Ni Chuanaigh, Director
The two-day interactive forum brings together manufacturers, regulators, and top industry experts to share and learn about the trends and strategies to address the challenges associated with the new guidelines. With a focus on solutions for the implementation of the new EU GMP Annex 1, the event will feature discussions around new methods, emerging tools, and the latest developments in new innovative technologies.
As regulatory compliance experts in sterile manufacturing, Lachman will engage attendees in how to minimize the myriad of complexities in preparing for the update and comply with the new requirements. Lachman has a unique methodology to help companies identify vulnerabilities and take proactive action to ensure you are prepared well in advance of the August effective date.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry.
Don’t miss this opportunity to hear how your peers are addressing the new challenges, the methods they’re employing, and the innovative technologies that are powering their journeys.
Meet Lachman at Booth 8. We look forward to helping you forge a path towards compliance and success in aseptic manufacturing.
For more information about the 2023 PDA Good Aseptic Manufacturing Conference, click here.
